Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Fentanyl Panpharma 0.5mg°

Fentanyl Panpharma 0.5mg° :
Type Medicine Withdrawn
Originator Fentanyl Janssen*
Agent Minapharm Halabi
Distributor Minapharm Halabi
Laboratory Panpharma
Responsible Party Panpharma
Origin France
Manufacturer Panpharma GmbH
Manufacturing Type G
Origin Germany
ATC N01AH01

Your comment will appear shortly after approval

Fentanyl Panpharma 0.5mg° :

Revision Date : 28/07/2016


Effect Frequency
Agitation postoperative Uncommon
Anaesthetic complication neurological Common
Anaphylactic reactions Not known
Anaphylactic shock Not known
Apnoea (Apnea) Common
Arrhythmia Common
Bradycardia Common
Bronchospasm Common
Cardiac arrest Not known
Cephalea Uncommon
Chills Uncommon
Confusion postoperative Common
Consciousness loss Not known
Convulsion Not known
Dermatitis allergic Common
Dyskinesia Common
Euphoric mood Uncommon
Hiccups Uncommon
Hypersensitivity Not known
Hypertension Common
Hyperventilation Uncommon
Hypotension Common
Hypothermia Uncommon
Intraocular pressure fluctuation Uncommon
Labile blood pressure Uncommon
Laryngospasm Common
Lightheadedness Common
Muscle rigidity Very Common
Myoclonus Not known
Nausea Very Common
Phlebitis Uncommon
Procedural complication Uncommon
Pruritus Not known
Respiratory depression Not known
Sedation Common
Tachycardia Common
Urticaria Not known
Vein pain Common
Visual disturbance Common
Vomiting Very Common

Different Units By MoH Code

Fentanyl Panpharma 0.5mg°  MoH 8856 :
Form Solution for injection
Packaging Glass Ampoules
Package Size 10x10ml
Strength 500µg
Storage Condition <25°C protect from light
NSSF ✘
Quarantine ✘
Reg. Number 155916/1
Submission date 01/01/2016
Registration Year 2017
Withdrawn Date 05/10/2026

Price Comparison

Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info